Skip to main content
William Flynn, MD, Ophthalmology, San Antonio, TX

WilliamJohnFlynnMD

Ophthalmology San Antonio, TX

Glaucoma Related, Retinal Disease

Physician

Dr. Flynn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Flynn's full profile

Already have an account?

  • Office

    5430 Fredericksburg Rd
    Suite 100
    San Antonio, TX 78229
    Phone+1 210-340-1212
    Fax+1 210-525-9617

Education & Training

  • San Antonio Uniformed Services Health Education Consortium
    San Antonio Uniformed Services Health Education ConsortiumResidency, Ophthalmology, 1992 - 1995
  • National Capital Consortium
    National Capital ConsortiumInternship, Transitional Year, 1990 - 1991
  • UniforMed Services University of the Health Sciences F. Edward Hebert School of Medicine
    UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1990

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2005 - 2026
  • OH State Medical License
    OH State Medical License 1992 - 2009
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Medflow EHR, Medflow, Inc., 2013
  • Fellow (FAAO) American Academy of Ophthalmology

Publications & Presentations

PubMed

  • Reply.
    Davinder S Grover, William J Flynn, Kent P Bashford, Richard A Lewis, Yi-Jing Duh
    American Journal of Ophthalmology. 2018-04-01

Press Mentions

  • Eyenovia Announces Publication of MIST Pivotal Studies Demonstrating the Efficacy and Safety of Its MAP™ Fixed-Combination Tropicamide-Phenylephrine Product for Mydriasis
    Eyenovia Announces Publication of MIST Pivotal Studies Demonstrating the Efficacy and Safety of Its MAP™ Fixed-Combination Tropicamide-Phenylephrine Product for MydriasisMarch 17th, 2021

Professional Memberships